SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-1.2%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$325M
AUM Growth
+$325M
(-25%)
Cap. Flow
-$95.5M
Cap. Flow
% of AUM
-29.39%
Top 10 Holdings %
Top 10 Hldgs %
41.07%
Holding
128
New
24
Increased
25
Reduced
26
Closed
27
Top Buys
| 1 |
Merck
MRK
|
$8.83M |
| 2 |
CELG
Celgene Corp
CELG
|
$8.1M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.26M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$4.35M |
| 5 |
SHPG
Shire pic
SHPG
|
$4.26M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$16.1M |
| 2 |
Eli Lilly
LLY
|
$16.1M |
| 3 |
Biogen
BIIB
|
$15.7M |
| 4 |
Pfizer
PFE
|
$14.4M |
| 5 |
Amgen
AMGN
|
$11M |
Sector Composition
| 1 | Healthcare | 73.82% |
| 2 | Technology | 6.62% |
| 3 | Communication Services | 3.39% |
| 4 | Industrials | 2.23% |
| 5 | Consumer Discretionary | 1.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.73M | 0.94% |
+45,000
| New | +$3.73M |
|
|
ARAV
27
DELISTED
Aravive, Inc. Common Stock
ARAV
| $3.73M | 0.94% |
250,000
+50,000
| +25% | +$745K |
|
28
Amicus Therapeutics
FOLD
$2.42B
| $3.63M | 0.92% |
730,000
-175,000
| -19% | -$870K |
|
29
FibroGen
FGEN
$48.4M
| $3.33M | 0.84% |
155,700
+10,000
| +7% | +$214K |
|
30
Vertex Pharmaceuticals
VRTX
$102B
| $3.32M | 0.84% |
+45,000
| New | +$3.32M |
|
31
Fidelity National Information Services
FIS
$35.6B
| $3.29M | 0.83% |
43,503
-4,657
| -10% | -$352K |
|
32
Air Products & Chemicals
APD
$64.8B
| $3.04M | 0.77% |
21,165
+120
| +0.6% | -$228K |
|
33
Schlumberger
SLB
$52.2B
| $2.89M | 0.73% |
+34,361
| New | +$2.89M |
|
|
GNCA
34
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.87M | 0.73% |
696,273
+87,002
| +14% | +$358K |
|
|
DBVT
35
DBV Technologies
DBVT
$249M
| $2.78M | 0.7% |
79,058
| – | – |
|
36
Travere Therapeutics
TVTX
$1.75B
| $2.73M | 0.69% |
143,974
-46,026
| -24% | -$871K |
|
37
Advance Auto Parts
AAP
$3.54B
| $2.72M | 0.69% |
16,059
+1,490
| +10% | +$252K |
|
|
TSRO
38
DELISTED
TESARO, Inc.
TSRO
| $2.69M | 0.68% |
20,000
-30,000
| -60% | -$4.04M |
|
39
Clearside Biomedical
CLSD
$26.7M
| $2.68M | 0.68% |
300,000
+73,900
| +33% | +$661K |
|
40
Nice
NICE
$8.48B
| $2.64M | 0.67% |
38,323
-47,717
| -55% | -$3.28M |
|
|
XLRN
41
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.55M | 0.65% |
+100,000
| New | +$2.55M |
|
42
Starbucks
SBUX
$99.2B
| $2.53M | 0.64% |
45,631
+4,031
| +10% | +$224K |
|
43
Xenon Pharmaceuticals
XENE
$2.99B
| $2.53M | 0.64% |
328,029
+100,000
| +44% | +$770K |
|
44
Rocket Pharmaceuticals
RCKT
$358M
| $2.45M | 0.62% |
401,764
| – | – |
|
|
GNMX
45
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $2.33M | 0.59% |
450,000
| – | – |
|
|
PTLA
46
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.24M | 0.57% |
+100,000
| New | +$2.24M |
|
|
KITE
47
DELISTED
Kite Pharma, Inc.
KITE
| $2.24M | 0.57% |
50,000
| – | – |
|
48
Ardelyx
ARDX
$1.57B
| $2.16M | 0.55% |
151,813
| – | – |
|
|
PRTK
49
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.16M | 0.55% |
140,000
| – | – |
|
|
AVXS
50
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.15M | 0.54% |
45,000
-55,000
| -55% | -$2.63M |
|